Emilie Dassé
Emilie Dassé is an expert in Hematology at Unicancer (France). Emilie Dassé has authored 10 publications, the most recent in 2025. SLR score: 34 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2025
Number : 10
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study. PMID 40795480 — safety, breast neoplasms, neoplasms, vinorelbine, fatigue, breast, therapeutics | Breast | 2025 | 0 |
| Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction. PMID 26631113 — genes, myb, cells, hematology, neoplasms, leukemia, leukemia, myeloid, acute, leukemia, myeloid, therapeutics, small molecules | Blood | 2015 | 99 |
| C/EBPα and MYB regulate FLT3 expression in AML. PMID 23340802 — cells, mutation, proto-oncogenes, leukemia, gene expression, introns, ccaat-enhancer-binding proteins, fms-like tyrosine kinase 3, promoter regions, genetic, genes, myb | Leukemia | 2013 | 30 |
| Itga2b regulation at the onset of definitive hematopoiesis and commitment to differentiation. PMID 22952660 — hematopoiesis, cells, megakaryocytes, genes, blood platelets, up-regulation, promoter regions, genetic | PLoS One | 2012 | 31 |
| Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells. PMID 22829978 — leukemia, myeloid, myeloid cells, gene expression, rna polymerase ii, genes, myb | Blood Cancer J | 2012 | 26 |
LeadR Networks
Main global connection map